PDC Therapeutics is a clinical-stage biotechnology start-up developing smart nanomedicines for targeted therapies via a Polymer Drug Conjugate technology yielding to an optimal therapeutic index based on the innovative Sagitta™ technology.

Some insights
Location
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2020
  • Number of employees in Switzerland
    1-9